Drugs Made In America Acquisition (DMIIR) Shares Outstanding (Diluted Average) (2024 - 2025)
Drugs Made In America Acquisition (DMIIR) reported Shares Outstanding (Diluted Average) of $14.4 million for Q4 2025, up 15.41% year-over-year from $12.5 million in Q4 2024, and up 430.91% on a QoQ basis from $2.7 million in Q3 2025.
Drugs Made In America Acquisition (DMIIR) has 2 years of Shares Outstanding (Diluted Average) data on file, last reported at $14.4 million in Q4 2025.
- Quarterly Shares Outstanding (Diluted Average) rose 15.41% year-over-year to $14.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.4 million (up 15.41% YoY) and the FY2025 annual result came in at $14.4 million, up 15.41% from the prior year.
- Shares Outstanding (Diluted Average) advanced to $14.4 million in Q4 2025 per DMIIR's latest filing, from $2.7 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $14.4 million in Q4 2025 and bottomed at $2.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 46.95 Mn |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | 7.50 Mn |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 7.91 Mn |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 8.63 Mn |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 25.80 Mn |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | 27.60 Mn |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | - |
| 10 | Drugs Made In America Acquisition | - | - | - | 14.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.43 Mn |
| Sep 30, 2025 | 2.72 Mn |
| Dec 31, 2024 | 12.50 Mn |